4.5 Article

Chemical space screening around Phe(3) in opioid peptides: Modulating mu versus delta agonism by Suzuki-Miyaura cross-couplings

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 28, 期 13, 页码 2320-2323

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2018.05.015

关键词

Opioid peptides; GPCR ligands; Non-natural amino acids; Suzuki-Miyaura cross coupling; Receptor selectivity

资金

  1. Agency Flanders Innovation and Entrepreneurship (VLAIO)
  2. Janssen Pharmaceutica
  3. Canadian Institutes of Health Research (CIHR) [MOP-123399, MOP-136871, FDN-148413]
  4. NIH [DA004443]
  5. CIHR [MOP-89716]
  6. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004443, R37DA004443] Funding Source: NIH RePORTER

向作者/读者索取更多资源

In this study, affinities and activities of derivatized analogues of Dmt-dermorphin[1-4] (i.e. Dmt-D-Ala-Phe-GIyNH(2), Dmt = 2',6'-dimethyl-(S)-tyrosine) for the mu opioid receptor (MOP) and delta opioid receptor (DOP) were evaluated using radioligand binding studies, functional cell-based assays and isolated organ bath experiments. By means of solid-phase or solution-phase Suzuki-Miyaura cross-couplings, various substituted regioisomers of the phenylalanine moiety in position 3 of the sequence were prepared. An 18-membered library of opioid tetrapeptides was generated via screening of the chemical space around the Phe(3) side chain. These substitutions modulated bioactivity, receptor subtype selectivity and highly effective ligands with subnanomolar binding affinities, contributed to higher functional activities and potent analgesic actions. In search of selective peptidic ligands, we show here that the Suzuki-Miyaura reaction is a versatile and robust tool which could also be deployed elsewhere. (C) 2018 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据